[HTML][HTML] Chinese experts' consensus on the Internet of Things-aided diagnosis and treatment of coronavirus disease 2019 (COVID-19)

L Bai, D Yang, X Wang, L Tong, X Zhu, N Zhong, C Bai… - Clinical eHealth, 2020 - Elsevier
The aim is to diagnose COVID-19 earlier and to improve its treatment by applying medical
technology, the “COVID-19 Intelligent Diagnosis and Treatment Assistant Program (nCapp)” …

Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19

…, Z Chen, Y Zhao, S Li, N Zhang, N Zhong… - JAMA internal …, 2020 - jamanetwork.com
Importance Early identification of patients with novel coronavirus disease 2019 (COVID-19)
who may develop critical illness is of great importance and may aid in delivering proper …

[HTML][HTML] Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

H Zhang, JM Penninger, Y Li, N Zhong… - Intensive care medicine, 2020 - Springer
A novel infectious disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
was detected in Wuhan, China, in December 2019. The disease (COVID-19) …

Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China

…, F Ye, J Zheng, N Zhang, Y Li, J He, S Li, N Zhong… - Chest, 2020 - Elsevier
Background The novel coronavirus disease 2019 (COVID-19) has become a global health
emergency. The cumulative number of new confirmed cases and deaths are still increasing …

[HTML][HTML] Public health measures and the control of COVID-19 in China

…, W Luo, H Huang, Y Zhang, H Wang, N Zhong… - Clinical reviews in …, 2021 - Springer
In December 2019, the COVID-19 pandemic quickly spread throughout China and beyond,
posing enormous global challenges. With prompt, vigorous, and coordinated control …

Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey

N Zhong, C Wang, W Yao, P Chen, J Kang… - American journal of …, 2007 - atsjournals.org
Rationale: The prevalence of chronic obstructive pulmonary disease (COPD) in China is
largely unknown. Objectives: To obtain the COPD prevalence in China through a large-…

[HTML][HTML] Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque

…, Q Wei, J Xu, Y Liu, B Zheng, MC Woodle, N Zhong… - Nature medicine, 2005 - nature.com
Abstract Development of therapeutic agents for severe acute respiratory syndrome (SARS)
viral infection using short interfering RNA (siRNA) inhibitors exemplifies a powerful new …

Treatment with convalescent plasma for influenza A (H5N1) infection

B Zhou, N Zhong, Y Guan - New England Journal of Medicine, 2007 - Mass Medical Soc
To the Editor: A previously healthy 31-year-old male van driver presented to a local clinic in
Shenzhen, in southern China, on June 7, 2006, with a 4-day history of a high fever (…

Abnormal pulmonary function in COVID-19 patients at time of hospital discharge

…, P Peng, C Lei, R Chen, N Zhong… - European …, 2020 - Eur Respiratory Soc
On 11 March 2020, the World Health Organization (WHO) declared coronavirus disease
2019 (COVID-19) as a pandemic. As of 22 April, more than 2.4 million cases have been …

[HTML][HTML] Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions

…, B Liu, Z Wang, S Zhang, Y Wang, N Zhong… - Journal of thoracic …, 2020 - ncbi.nlm.nih.gov
Background The coronavirus disease 2019 (COVID-19) outbreak originating in Wuhan,
Hubei province, China, coincided with chunyun, the period of mass migration for the annual …